Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00949013
What this trial is testing

S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 1,600
Not applicableEnded earlyNCT04951284
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 42
Not applicableStudy completedNCT02310984
What this trial is testing

PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional

Who this might be right for
Early-Stage Breast Carcinoma
University College, London 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT04015778
What this trial is testing

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

Who this might be right for
Non Small Cell Lung Cancer
Guangdong Association of Clinical Trials 316
Early research (Phase 1)Looking for participantsNCT06324240
What this trial is testing

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more
Emory University 18
Large-scale testing (Phase 3)Study completedNCT01352117
What this trial is testing

Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma

Who this might be right for
HIV-1 InfectionKaposi's Sarcoma
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 192
Not applicableLooking for participantsNCT06385717
What this trial is testing

Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer

Who this might be right for
Esophagus Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 120
Early research (Phase 1)Ended earlyNCT01445340
What this trial is testing

Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma

Who this might be right for
Mycosis FungoidesCutaneous T-Cell LymphomaNeoplasms
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT00421876
What this trial is testing

GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study

Who this might be right for
Myocardial Infarction
Heart Care Foundation 3,200
Not applicableNot Yet RecruitingNCT07698990
What this trial is testing

Segmentectomy Versus Lobectomy for Deep Solid-Dominant Early-Stage NSCLC

Who this might be right for
Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Cancer
Shanghai Chest Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT00349089
What this trial is testing

Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy

Who this might be right for
Non Small Cell Lung Cancer
Thoraxklinik-Heidelberg gGmbH 132
Not applicableUnknownNCT01102517
What this trial is testing

A Trial on Video-assisted Thoracoscopic Surgery and Axillary Thoracotomy for Resection of Early-stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 500
Testing effectiveness (Phase 2)Study completedNCT00281736
What this trial is testing

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Who this might be right for
Esophageal CancerPrecancerous Condition
Roswell Park Cancer Institute 60
Not applicableStudy completedNCT04287712
What this trial is testing

Detection of Lung Cancer by Plasma Lipids

Who this might be right for
Early-Stage Lung Cancer
Peking University People's Hospital 558
Not applicableStudy completedNCT03691428
What this trial is testing

Stress Reduction Study for Partners of Early Stage Dementia

Who this might be right for
Dementia Caregiving
Yale University 90
Not applicableLooking for participantsNCT05386719
What this trial is testing

Cardiometabolic Screening Program

Who this might be right for
Breast CancerEarly-stage Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 450
Not applicableStudy completedNCT01658930
What this trial is testing

Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

Who this might be right for
Cervical Cancer
Canadian Cancer Trials Group 700
Not applicableLooking for participantsNCT03390894
What this trial is testing

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Who this might be right for
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group 8,000
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)Study completedNCT01676831
What this trial is testing

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Who this might be right for
Cutaneous T Cell Lymphoma
Abramson Cancer Center at Penn Medicine 13
Next Page